Hair Loss on Ozempic, Wegovy, or Zepbound: How Common It Really Is, Why Women Get It More, and Does It Grow Back? (New 2026 Research)

Do weight loss shots like Ozempic, Wegovy, Mounjaro, and Zepbound make your hair fall out? Yes, for some people, and 2026 has been the year the research finally caught up with what users were saying online. The short version: it is real, it is more common in women and in people who lose weight fast, it is mostly the shedding kind that grows back, and men get it far less often than you would guess from social media. Here is what the drug labels, the new studies, and people shedding hair this month actually say.

Short answer

It is real. The current US labels for Zepbound and Wegovy both list hair loss as a side effect, and a large BMJ study from July 2026 found a higher risk than with other diabetes drugs.
The numbers are small in trials, bigger in real life. Trials show a few percent. Surveys of real users show far more people noticing extra shedding.
Women get it much more than men. On both labels, the gap is huge.
Most of it is temporary shedding. The common type is called telogen effluvium. It usually slows once your weight settles, and the hair tends to come back over months.
Speed matters. The faster and the more you lose, the more likely you are to shed.

What the drug labels say (updated 2026)

The official US labels are the most solid numbers, because they come from placebo controlled trials.

Zepbound (tirzepatide), label revised August 2026. Hair loss is on its list of most common side effects. In the two main weight loss trials, it was reported in 7.1% of women on the drug vs 0.5% of men. On placebo it was 1.3% of women and 0% of men. No one on the drug quit the trials because of it. The label says the hair loss was "associated with weight reduction."
Wegovy (semaglutide), label revised June 2026. In the main weight loss trials, 3.3% on the standard dose reported hair loss (4% of women, 0.9% of men) vs 1% on placebo. In trials of the newer, higher dose on the same label, it was 5.8% (8.4% of women and just 0.2% of men).

So in trials, a man on these drugs had well under a 1 in 100 chance of reporting hair loss. For women it was closer to 1 in 12 to 1 in 14 on the stronger options.

New research (May to October 2026)

This year brought the first big studies built to answer the question properly.

BMJ, July 22, 2026. Researchers at the University of Pennsylvania compared about 12,000 people with type 2 diabetes who started a GLP-1 drug against people who started two other common diabetes drug types. After adjusting for differences, GLP-1 users had a 37% higher risk of hair loss than one group and 68% higher than the other. The risk was in the non scarring kind (like telogen effluvium), and most cases showed up in the first year, peaking just before 12 months. The absolute risk was small: about 7 cases per 1,000 people per year vs about 4 to 5 on the other drugs.
Meta analysis, Skin Appendage Disorders, June 30, 2026. Pooling 17 studies with more than a million patient records, GLP-1 drugs were tied to about a 40% higher risk of non scarring hair loss. That included shedding and also pattern hair loss. The patchy autoimmune type (alopecia areata) was not linked.
Trial meta analysis, Diabetes Research and Clinical Practice, May 2026. Across 9 trials with 4,114 GLP-1 users, hair loss was about 3 times more likely than on placebo, and about 3.9% of users reported it.
Big US records study, JAAD, June 2026 issue. Comparing more than 576,000 matched patients per group against metformin users, semaglutide and tirzepatide were tied to more shedding and more pattern hair loss, starting as early as 6 months. Weight changes in that study were modest, so the authors said fast weight loss may not explain all of it.
Tirzepatide vs semaglutide, July 20, 2026 preprint (not yet peer reviewed). In about 12,900 matched users per drug, new hair loss within a year was 4.20% on tirzepatide vs 2.88% on semaglutide. Even when matched for the same amount of weight lost, tirzepatide was still higher. Most people who developed it on tirzepatide were women, and they more often had thyroid problems or irregular periods.
Real user survey, Journal of Cosmetic Dermatology, 2026. In 504 US users (90% women), 38.9% noticed some hair change, mostly shedding (20.8%) and thinning (19.0%). Of those who shed, 42% noticed it within the first 1 to 3 months. Hair problems were worse in people who lost 40 pounds or more. White users mostly reported shedding, while Black users more often reported dryness and breakage. Even so, 92% were happy with the treatment.

The twist: the Ozempic maker wants into hair loss

On September 22, 2026, Novo Nordisk, the company behind Ozempic and Wegovy, said hair loss is one of the areas it is eyeing as it grows its direct to consumer business. Its chief science officer said some new hair loss science is rooted in hormones, Novo's home turf, but that it is not the first thing it will pursue. Any product would be years away.

Why the numbers jump around

An October 14, 2026 review in Acta Diabetologica put it bluntly: hair loss shows up in about 3% to 7% of people in trials but over 70% in some real world groups. Trials only count it when people report it as a side effect. Surveys ask everyone if they noticed anything. Both are true in their own way. Many people notice some extra hair in the drain, and a smaller group loses enough that it shows.

Why it happens

Fast weight loss is the main trigger. Losing a lot of weight quickly is a known stressor that pushes many hairs into their resting phase at once. They fall out a few months later. The American Academy of Dermatology lists losing 20 pounds or more as a common cause of this shedding.
Eating too little. These drugs cut appetite hard. Low protein, low calories, and low iron can all stress hair. A June 2026 review in Nutrients flagged iron deficiency as a newly recognized issue on these drugs, from eating less and possibly absorbing less.
Possibly the drug itself. A September 2026 review in Biology proposed that changes in the fat layer around hair roots may play a part. This is still a theory.
Your own genes. Several studies found more pattern hair loss, not just shedding. A big shed can make thinning you were already headed for show up sooner.

A 2024 study of 140 people with weight loss related shedding found it started at an average loss of about 15% of body weight, at an average pace of about 3.5 kg a month. Women and older adults shed even when they lost less.

When does it stop, and does it grow back?

The AAD says this kind of shedding usually shows up a few months after the trigger and tends to return to normal fullness within 6 to 9 months once the body settles. If the stress keeps going, like nonstop fast weight loss or long term under eating, the shedding can drag on.

That matches the BMJ data, where most cases clustered in the first year. It also matches a post this month from someone near goal weight saying the shedding finally slowed. The bad news for long hair: regrowth is slow, about the normal speed of hair growth, so length takes years to come back.

What people shedding hair say (October 2026)

Many people online say the shedding is the side effect they feared most. Here is what posts from the past few weeks describe.

"Tons of hair loss" but no regrets. One user who lost 50 pounds since May at about 2 pounds a week, while walking an hour a day and lifting five days a week, said they had tons of hair loss but started with very thick hair.
Doing everything right and still shedding. A 28 year old woman said she had four months of constant shedding even with lots of protein and new biotin, and her weight had stalled.
Panic at a modest loss. A user down about 11 pounds since mid August said they felt they were shedding more right after a dose increase and had already ordered a hair, skin, and nails vitamin.
Lessons from the last time. A new user who lost about half their hair after fast weight loss in 2023 said it grew back full and long after the weight came back, and planned to lose slowly this time. A college student who lost about 75% of her hair volume on an earlier GLP-1 run said she was starting weight training and more protein before starting again.
Eyebrows too. One user noticed their eyebrows thinning, not just their scalp.
Shedding after stopping. A user who stopped two months earlier due to insurance, after 2 to 3 months and 8 to 10 pounds lost, said heavy shedding started after stopping. That fits the delay of this kind of shedding, which shows up months after the trigger.
Slow loss, still thinning. On Oct. 28, a 37 year old woman losing only about half a pound a week said her hair was much thinner and not growing back, even with lots of protein and normal blood work, including iron stores and thyroid. Slow loss lowers the odds, but it is not a guarantee.
Steady loss, steady shedding. A user who went from 88 kg to 72 kg since April, about 2 kg a month, said they were finding hair on the pillow and in the drain even while taking iron, vitamin D, and zinc.
Scalp pain that ended it. On Oct. 31, a user down 20 pounds since June said that after a dose increase their scalp and hair hurt and parts of their skin felt sunburnt with nothing visible. After moving up again, they quit.
Scalp pain and the pill. On Oct. 31, another user posted about GLP-1 hair loss together with scalp pain, which doctors call trichodynia, and minoxidil. A different user said a week of oral minoxidil for hair loss after 10 months on the drug brought horrible nausea.
A man with the family pattern. On Oct. 15, a 24 year old man who lost about 50 pounds in almost a year on tirzepatide said his crown was visibly thinning and his dad is mostly bald. He admitted he is often in a calorie deficit and misses his protein goals. He tried finasteride for about a week and stopped after nightly anxiety. His case shows how fast loss, under eating, and genes can stack.
Covering up. One woman with past scarring hair loss from lupus said the extra GLP-1 thinning pushed her to order a custom hair topper.
At goal weight. A user near goal weight said the shedding seemed to slow, but joked it could be because there was less hair left to lose.

Lesser-known tips

Men, your odds are low. In trials, under 1% of men reported hair loss on either drug. If you are a man thinning fast on one of these, there is a real chance it is your normal pattern hair loss showing up, which needs a different plan than waiting it out.
Scalp pain can be part of it. The Wegovy label lists "dysesthesia," which includes skin pain and burning skin, in up to 22% of people on the higher dose in trials vs 0% on placebo. Some people with shedding also report a sore scalp, and one user this month quit over it. It is a listed side effect, not proof you are going bald.
Biotin is not the fix. Many people online grab biotin or hair vitamins. A 2017 review of diet and hair loss found no good evidence that biotin helps people who are not low in it, and true lack of it is rare. The FDA also warns that biotin can throw off some lab tests, including a key heart attack test.
Iron and protein are the real checks. The 2026 reviews point to iron, protein, and overall calories. A September 2026 review in Clinics in Dermatology said management starts with enough protein and explaining the timeline to patients.
Slow loss sheds less. The 2024 shedding study and the 2026 survey both tie more shedding to more and faster weight loss.
Do not judge by week 2. Shedding from weight loss usually shows up a month or more in, often a few months. In the first days of a new drug, you may just be noticing normal shedding because you are watching closely. The AAD says losing 50 to 100 hairs a day is normal.
The drug may change how your other pills work. These drugs slow how fast your stomach empties. The BMJ authors noted this may change how well some pills are absorbed, and one person online this month asked if it changes how oral minoxidil works. Nobody has studied that yet, so be careful about changing other hair pills at the same time you start or raise a GLP-1.
Hair can get better too. The October 2026 Acta Diabetologica review and the June meta analysis noted some people with certain scarring scalp conditions improved on these drugs, likely because their overall health improved.

Fair take: positives and negatives

Positives:

For most people, the shedding is temporary and grows back.
Men are rarely affected in trials.
In the 2026 survey, 92% of users were happy with the treatment despite skin and hair changes.

Negatives:

For women, the risk is real, around 1 in 12 or more on the stronger options in trials and much higher in surveys.
Regrowth takes many months, and long hair takes years to look the same.
Some studies tie these drugs to more pattern hair loss, which does not grow back on its own.
Tirzepatide may carry more risk than semaglutide, though that data is still a preprint.

Bottom line

Hair loss on GLP-1 shots is not an internet myth, but it is also not the hair apocalypse some videos make it out to be. For most people it is a temporary shed caused by losing weight fast while eating too little, and it grows back once the weight settles. Women and fast losers get hit the most. Men rarely do, so a man going thin on these drugs should suspect his genes, not just the shot. Eat enough protein, do not crash your calories, lose at a pace your body can handle, and expect your hair to take its time.

If you are losing weight and your face and hair are changing, you can see how your new photos actually come across. The Face They See lets people of the opposite gender rank your photos for free.

Related guides

See all guides